Doximity, Inc. engages in the development and operation of an online platform for medical professionals. Its cloud-based software has the ability to enable users to collaborate with their ...

Bearish flow noted in Doximity (DOCS) with 4,572 puts trading, or 1.6x expected. Most active are Apr-25 60 puts and Apr-25 65 puts, with total ...

While the historical EPS growth rate for Doximity is 17.5%, investors should actually focus on the projected growth. The company's EPS is expected to grow 32.6% this year, crushing the industry ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

In trading on Tuesday, shares of Doximity Inc (Symbol ... and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of DOCS shares: Looking ...

Cencora, Doximity and Pediatrix Medical are part of the Zacks Industry Outlook article. The Zacks Medical - Services industry is undergoing a transformation on massive artificial intelligence ...

Doximity is Monday's pick for IBD 50 Growth Stocks To Watch as the physician online network stock tried to establish its footing on a day of harsh selling. Doximity stock is in a base with ...

Revenue of $126.7 million exceeded management's expectations. Adjusted EBITDA of $65.9 million was significantly above guidance. Annual guidance for revenue and adjusted EBITDA ranges increased.

Doximity (DOCS) ended the recent trading session at $62.99, demonstrating a +0.35% swing from the preceding day's closing price. The stock exceeded the S&P 500, which registered a gain of 0.08% ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Our proprietary system currently recommends Doximity (DOCS) as one such stock. This company not only has a favorable Growth Score, but also carries a top Zacks Rank. Studies have shown that stocks ...